pip4k2c Antibody

1.1. Definition and Basic Description

pip4k2c antibodies are specialized immunoglobulins designed to detect and bind specifically to phosphatidylinositol 5-phosphate 4-kinase type-2 gamma (PIP4K2C), a lipid kinase that catalyzes the conversion of phosphatidylinositol 5-phosphate (PI5P) to phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) . These antibodies are available in various formats, including monoclonal and polyclonal varieties, and are used in multiple applications such as western blotting, immunohistochemistry, ELISA, and immunofluorescence. The antibodies recognize specific epitopes on the PIP4K2C protein, allowing researchers to detect, quantify, and localize this protein in various biological samples, from cell cultures to tissue specimens and biological fluids.

1.2. Historical Context and Discovery

PIP4K2C was originally discovered as part of the phosphatidylinositol 5-phosphate 4-kinase (PIP4K) family, which includes three isoforms in mammals: PIP4K2A (α), PIP4K2B (β), and PIP4K2C (γ) . Initial studies on PIP4K2C mRNA expression demonstrated high levels in kidney, as reported by Itoh et al., with further research confirming significant expression in brain, heart, and testis compared to other tissues . The development of specific antibodies against PIP4K2C followed this discovery, enabling more detailed studies of the protein's expression patterns, subcellular localization, and biological functions. These antibodies have been instrumental in advancing our understanding of PIP4K2C's roles in various cellular processes and disease states.

1.3. Importance in Biochemical Research

PIP4K2C antibodies have become essential tools in biochemical and biomedical research, facilitating investigations into the roles of this lipid kinase in multiple cellular pathways . These antibodies enable the detection of PIP4K2C in various experimental settings, from basic protein expression studies to complex analyses of disease mechanisms. The importance of these antibodies has grown significantly as research has uncovered PIP4K2C's involvement in critical processes such as autophagy regulation, immune system modulation, and viral infection responses . Furthermore, the emerging role of PIP4K2C as a potential therapeutic target for conditions ranging from viral infections to cancer and neurodegenerative disorders has heightened the demand for high-quality, well-characterized antibodies against this protein .

2.1. Structure and Molecular Weight

PIP4K2C is a protein with a molecular weight of approximately 47 kDa according to theoretical calculations, although western blot analysis sometimes detects the protein at around 38 kDa . The protein consists of 421 amino acids and contains a conserved kinase domain characteristic of the PIP4K family . PIP4K2C's structure features an ATP-binding site within the kinase domain, which serves as the target for many inhibitors of this enzyme . Additionally, the protein contains a disordered loop near the ATP-binding site with a critical cysteine residue that can be targeted by covalent inhibitors, as demonstrated with compounds like THZ-P1-2 .

2.2. Protein Family Classification

PIP4K2C belongs to the type 2 phosphatidylinositol-5-phosphate 4-kinase family, which in mammals consists of three isoforms: PIP4K2A (α), PIP4K2B (β), and PIP4K2C (γ) . These kinases share significant sequence homology and catalyze the same biochemical reaction—phosphorylation of PI5P to generate PI(4,5)P2—but differ in their tissue distribution, subcellular localization, and catalytic efficiency . Among the three isoforms, PIP4K2C has the lowest enzymatic activity in vitro, suggesting that it may function primarily through non-catalytic mechanisms, such as protein scaffolding roles . The PIP4K family is part of the larger phosphoinositide kinase superfamily, which plays crucial roles in cell signaling, membrane trafficking, and cytoskeletal organization.

2.3. Physicochemical Properties

PIP4K2C exhibits several notable physicochemical properties that influence its function and detection. The protein is primarily cytosolic but can associate with membranes, particularly the endoplasmic reticulum, where it may play a role in local PI(4,5)P2 production . PIP4K2C's interaction with membranes is facilitated by specific domains that recognize membrane components. Despite having relatively low catalytic activity compared to other family members, PIP4K2C remains an important regulator of membrane lipid dynamics and phosphoinositide metabolism . The protein's ability to bind specific lipid substrates and interact with other regulatory proteins contributes to its diverse cellular functions beyond its enzymatic activity.

3.1. Tissue-Specific Expression Profiles

PIP4K2C exhibits distinct tissue-specific expression patterns that have been characterized through various techniques including RT-PCR, in situ hybridization, and immunohistochemistry . Quantitative PCR analyses have revealed particularly high expression levels in kidney, with significant expression also detected in brain, heart, and testis . In contrast, expression levels are comparatively lower in tissues such as liver, spleen, and muscle. This tissue-specific distribution suggests specialized roles for PIP4K2C in these organs. The detection of PIP4K2C protein in these tissues has been facilitated by specific antibodies, which have confirmed the mRNA expression patterns and provided additional insights into protein localization within tissue structures.

3.2. Subcellular Localization

At the subcellular level, PIP4K2C demonstrates a distinct localization pattern that differs somewhat from other PIP4K family members . The protein is predominantly found in the cytosol and surrounding plasma membrane, but its presence in the endoplasmic reticulum appears to be particularly important for PIP(4,5)P2 synthesis . Immunofluorescence studies using specific antibodies have been instrumental in revealing this subcellular distribution. Unlike PIP4K2A, which shows nuclear localization in some cell types, PIP4K2C is primarily cytoplasmic. This distinct subcellular localization may contribute to the specific functions of PIP4K2C in membrane trafficking and organelle dynamics, particularly in processes such as autophagy.

3.3. Expression Level Comparisons Across Tissues

Comparative analysis of PIP4K2C expression across different tissues reveals significant variations that may relate to tissue-specific functions. Table 3 summarizes the relative expression levels of PIP4K2C in various tissues based on multiple studies.

Table 3: Tissue Expression Patterns of PIP4K2C

In kidney tissue, PIP4K2C expression is confined to specific segments of the nephron within the cortical and medullary regions and is notably absent from the kidney vasculature . This specific localization pattern suggests specialized functions in renal physiology that warrant further investigation. In the brain, PIP4K2C shows region-specific expression patterns, with higher levels in certain neuronal populations compared to others . These tissue-specific expression patterns, revealed through the use of validated antibodies, provide valuable clues about the potential physiological roles of PIP4K2C in different organ systems.

4.1. PI5P to PI(4,5)P2 Conversion

The primary enzymatic function of PIP4K2C is the phosphorylation of phosphatidylinositol 5-phosphate (PI5P) to generate phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) . This reaction represents an alternative pathway for PI(4,5)P2 production, as most cellular PI(4,5)P2 is generated from PI4P via type I PI4P 5-kinases . Despite having relatively low catalytic activity compared to other PIP4K family members, PIP4K2C contributes to the maintenance of cellular PI(4,5)P2 levels, particularly in specific subcellular compartments such as the endoplasmic reticulum . The conversion of PI5P to PI(4,5)P2 by PIP4K2C affects the balance of phosphoinositide species within cells, influencing multiple cellular processes including signaling, membrane trafficking, and cytoskeletal organization.

4.2. Membrane Trafficking Regulation

Beyond its catalytic activity, PIP4K2C plays important roles in regulating membrane trafficking processes . Through its ability to modulate membrane lipid dynamics, particularly by influencing PI(4,5)P2 localization and clustering, PIP4K2C governs multiple aspects of membrane trafficking independently of its catalytic function . These functions include regulation of vesicle formation, transport, and fusion events that are essential for normal cellular physiology. PIP4K2C's involvement in membrane trafficking contributes to its roles in processes such as autophagy, endocytosis, and secretion, which are critical for maintaining cellular homeostasis and responding to various stressors.

4.3. Autophagy Modulation

One of the most significant functions of PIP4K2C is its role in regulating autophagy, a cellular process that degrades and recycles damaged organelles, misfolded proteins, and other cellular components . Research has shown that inhibition or knockdown of PIP4K2C enhances autophagic flux, promoting the clearance of cellular materials through the autophagy-lysosome pathway . This function has important implications for various pathological conditions, including neurodegenerative disorders characterized by protein aggregation, such as Huntington's disease . In these contexts, PIP4K2C inhibition has been shown to reduce levels of mutant huntingtin protein by enhancing its degradation through increased autophagy.

4.4. mTORC1 Signaling Pathway Regulation

PIP4K2C plays a crucial role in regulating the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway, an important controller of cellular growth, metabolism, and immune function . Studies with PIP4K2C knockout mice have demonstrated that loss of this protein leads to hyperactivation of mTORC1 signaling in various tissues, resulting in increased inflammation and immune activation . The regulatory relationship between PIP4K2C and mTORC1 has significant implications for conditions involving immune dysregulation, such as autoimmunity and inflammatory disorders. Furthermore, the ability of PIP4K2C to modulate mTORC1 signaling provides a mechanistic link between phosphoinositide metabolism and cellular growth control, with potential implications for cancer and metabolic disorders.

5.1. T-Cell Activation and Proliferation

PIP4K2C plays a significant role in regulating T-cell activation and proliferation, key processes in immune responses . Studies with Pip4k2c knockout mice have revealed increased T-cell activation and proliferation, particularly in aged animals . This hyperactivation is associated with an expansion of T-helper cell populations and enhanced production of proinflammatory cytokines. The use of specific antibodies against PIP4K2C has been instrumental in elucidating these immune regulatory functions, allowing researchers to track changes in protein expression and localization during T-cell activation events. The modulation of T-cell responses by PIP4K2C has important implications for both normal immune function and pathological conditions involving immune dysregulation.

5.2. Inflammatory Cytokine Production

PIP4K2C significantly influences the production of inflammatory cytokines, serving as a key regulator of immune responses . Knockout studies have demonstrated that deletion of the Pip4k2c gene leads to increased levels of proinflammatory cytokines in plasma, including interferon gamma (IFNγ), interleukin-12 (IL-12), and interleukin-2 (IL-2) . Table 4 summarizes the effects of PIP4K2C on inflammatory cytokine levels based on knockout studies and inhibitor treatments.

Table 4: PIP4K2C Effects on Inflammatory Cytokine Levels

The increased production of these cytokines contributes to the inflammatory phenotype observed in Pip4k2c knockout mice, characterized by immune cell infiltrates in various tissues including liver, intestine, kidney, and lungs . The detection and quantification of these cytokines have been facilitated by specific antibody-based assays, highlighting the importance of antibody technologies in studying the immunoregulatory functions of PIP4K2C.

5.3. Autoimmunity Mechanisms

PIP4K2C has been implicated in autoimmunity mechanisms through its regulation of immune cell activation and cytokine production . The hyperactivated immune phenotype observed in Pip4k2c knockout mice, characterized by increased T-helper cell populations and decreased regulatory T-cell populations, resembles aspects of autoimmune conditions . These changes lead to dysregulated immune responses that may contribute to tissue damage and chronic inflammation. The increased proportion of central memory T cells (CD44+ T cells) in these mice further supports the role of PIP4K2C in preventing inappropriate immune activation. Understanding these autoimmunity mechanisms has been greatly facilitated by antibody-based techniques that enable detailed analysis of immune cell populations and their activation states.

5.4. SNP rs1678542 and Autoimmune Association

A single nucleotide polymorphism (SNP) in the PIP4K2C locus, specifically rs1678542, has been associated with familial autoimmunity in humans . This genetic variation may influence PIP4K2C expression or function, potentially contributing to autoimmune susceptibility. Studies suggest that this SNP might cause a decrease in PIP4K2C expression, leading to increased mTORC1 signaling and subsequently enhanced immune activation . This association provides a potential mechanistic link between genetic variation, phosphoinositide signaling, and autoimmune disease risk. Antibodies against PIP4K2C have been valuable tools in investigating the molecular consequences of this genetic variation, allowing researchers to examine potential differences in protein expression or function associated with different genotypes.

6.1. SARS-CoV-2 Infection Mechanism

Recent research has uncovered a significant role for PIP4K2C in SARS-CoV-2 infection, the virus responsible for COVID-19 . Specifically, PIP4K2C has been found to directly interact with SARS-CoV-2 nonstructural protein 6 (NSP6) . This interaction suggests that PIP4K2C may be directly involved in regulating NSP6-mediated functions during viral infection. Antibodies against PIP4K2C have been instrumental in these discoveries, enabling researchers to detect protein-protein interactions through techniques such as co-immunoprecipitation and proximity labeling. The identification of this direct interaction between a host cell kinase and a viral protein represents an important advance in our understanding of SARS-CoV-2 pathogenesis.

6.2. Viral Replication Inhibition

PIP4K2C has emerged as a promising target for inhibiting viral replication, particularly for RNA viruses including SARS-CoV-2 . Studies have demonstrated that both genetic knockdown and pharmacological inhibition of PIP4K2C can potently suppress viral replication in cell culture and organoid models . In plaque assays using Calu-3 cells, knockdown of PIP4K2C suppressed SARS-CoV-2 replication by over 2 logs compared to control conditions . These findings have significant implications for antiviral drug development, suggesting that PIP4K2C inhibitors may represent a new class of broad-spectrum antivirals. Antibodies targeting PIP4K2C have played important roles in validating knockdown efficiency in these studies, ensuring that the observed antiviral effects are specifically due to reduced PIP4K2C expression.

6.3. Autophagy Modulation During Viral Infection

One of the key mechanisms through which PIP4K2C influences viral infection is by regulating autophagy, a cellular process that can both promote and restrict viral replication depending on the context . During SARS-CoV-2 infection, the virus appears to induce impairment of autophagic flux, potentially to create favorable conditions for its replication . PIP4K2C plays a critical role in this virus-induced autophagy dysregulation. Importantly, inhibition of PIP4K2C has been shown to reverse this autophagic flux impairment, representing a mechanism of antiviral action . Antibody-based detection methods, including western blotting for autophagy markers such as LC3-II, have been essential for characterizing these changes in autophagic flux. The ability of PIP4K2C inhibition to restore normal autophagy function provides a potential therapeutic strategy for combating SARS-CoV-2 and possibly other viral infections.

7.1. PIP4K2C Inhibitors and Their Mechanisms

Table 2: PIP4K2C Inhibitors and Their Effects

These inhibitors function through diverse mechanisms, including competitive ATP-binding site inhibition, covalent modification, and targeted protein degradation . The development of these compounds has been greatly facilitated by antibody-based assays that enable detection of target engagement and validation of inhibitor specificity. The varied mechanisms and selectivity profiles of these inhibitors provide researchers with a range of tools for investigating PIP4K2C functions and potential therapeutic applications.

7.2. Cancer Immunotherapy Applications

PIP4K2C has emerged as a promising target for cancer immunotherapy, particularly in the context of colorectal cancer (CRC) and other solid tumors . Research has demonstrated that targeted degradation of PIP4K2C by compounds such as LRK-A induces tumor regression in CRC models . The mechanism involves enhanced phagocytosis of dead tumor material by dendritic cells and increased uptake of apoptotic tumor cells, enabling a synergistic amplification of the immune response to cancer . In mouse models, LRK-A treatment as a single agent significantly reduced tumor growth, including full regressions in some cases . These findings suggest that PIP4K2C inhibition or degradation could represent a novel approach to "uncloaking" tumors, making them more visible to the immune system. Antibodies against PIP4K2C have been important tools in these studies, allowing researchers to monitor protein degradation and validate target engagement.

7.3. Neurodegenerative Disorder Treatment

PIP4K2C inhibition shows significant promise for treating neurodegenerative disorders, particularly those characterized by protein aggregation such as Huntington's disease . Studies have demonstrated that inhibition or genetic knockdown of PIP4K2C enhances autophagy, promoting the clearance of mutant huntingtin protein and reducing aggregate formation . In cellular models, PIP4K2C inhibitors such as NCT-504 reduced levels of mutant huntingtin protein by approximately 40% . Furthermore, genetic knockdown of PIP4K in Drosophila models of Huntington's disease ameliorated neuronal dysfunction and degeneration, as assessed using motor performance and retinal degeneration assays . These findings suggest that PIP4K2C inhibitors could represent a novel therapeutic approach for Huntington's disease and potentially other neurodegenerative disorders characterized by protein aggregation. Antibodies against PIP4K2C have been crucial in these studies, enabling researchers to confirm knockdown efficiency and examine the effects on downstream pathways.

7.4. Cardiovascular Disease Therapy

PIP4K2C represents a potential therapeutic target for cardiovascular diseases, particularly heart failure associated with cardiac hypertrophy and fibrosis . Research has shown that PIP4K2C is significantly downregulated in the hearts of patients with cardiac hypertrophy and heart failure compared to non-injured hearts . In a mouse model of pressure overload-induced heart failure, transient upregulation of Pip4k2c using a modified mRNA (modRNA) gene delivery platform significantly improved heart function, reversed cardiac hypertrophy and fibrosis, and led to increased survival . Mechanistically, Pip4k2c appears to inhibit TGFβ1 signaling via its N-terminal motif, thereby reducing fibrotic responses . These findings suggest that PIP4K2C-targeted therapies, particularly those using modRNA approaches, might represent a translatable gene therapy approach for heart failure treatment. Antibodies against PIP4K2C have been valuable tools in these cardiovascular studies, enabling researchers to monitor protein expression changes in both clinical samples and experimental models.

7.5. Antiviral Therapeutic Potential

The discovery of PIP4K2C's role in viral infections, particularly SARS-CoV-2, has highlighted its significant potential as an antiviral therapeutic target . Inhibitors such as RMC-113, which target both PIP4K2C and PIKfyve, have demonstrated potent suppression of multiple RNA viruses, including SARS-CoV-2, in human lung organoids . The mechanism involves altering virus-induced phosphoinositide signatures and reversing autophagic flux impairment caused by viral infection . These findings suggest that dual inhibition of PIP4K2C and PIKfyve could represent a promising strategy for developing broad-spectrum antivirals to combat emerging viral threats . Antibodies against PIP4K2C have been essential tools in these antiviral studies, enabling researchers to validate target engagement and examine the effects of inhibitors on protein-protein interactions relevant to viral infection processes.

8.1. Mouse Model Development

Multiple research groups have developed Pip4k2c knockout mouse models to investigate the physiological and pathological roles of this lipid kinase . These models involve genetic deletion of the Pip4k2c gene, resulting in complete absence of the protein product. The specificity of gene deletion has been verified using various techniques, including genomic PCR, RT-PCR, and western blotting with specific antibodies against PIP4K2C . These knockout models have proven to be valuable tools for studying the functions of PIP4K2C in vivo, revealing phenotypes that might not be apparent from cell culture studies alone. The development and characterization of these mouse models have been greatly facilitated by antibody-based techniques that enable verification of protein absence and examination of effects on related signaling pathways.

8.2. Immune System Phenotypes

Pip4k2c knockout mice exhibit distinctive immune system phenotypes, particularly as they age . These include increased immune cell infiltrates in various tissues, including liver, intestine, kidney, and lungs . The infiltrating cells are predominantly T cells and B cells, suggesting a dysregulation of adaptive immune responses. Additionally, these mice show expanded T-helper cell populations and decreased regulatory T-cell populations, reflecting an imbalance in immune regulation . The increase in CD44-positive T cells (central memory T cells) in these mice further supports the hyperactivation of their immune system . These immune phenotypes are associated with elevated levels of proinflammatory cytokines in plasma, as detected using antibody-based assays. Importantly, treatment with rapamycin, an mTORC1 inhibitor, reduces these inflammatory phenotypes, suggesting that hyperactivation of mTORC1 signaling contributes to the observed immune dysregulation .

8.3. Cardiovascular Effects

Studies of Pip4k2c knockout mice have revealed significant cardiovascular phenotypes, particularly in response to pathological stress . While deletion of Pip4k2c does not affect normal embryonic cardiac development, adult Pip4k2c knockout mice subjected to transverse aortic constriction (TAC), a model of pressure overload, develop more severe cardiac hypertrophy, fibrosis, and higher rates of sudden death compared to wild-type mice . These findings suggest that PIP4K2C plays a protective role in the heart during pathological stress, potentially by inhibiting pro-hypertrophic and pro-fibrotic signaling pathways. The characterization of these cardiovascular phenotypes has been facilitated by antibody-based techniques, including immunohistochemistry for detecting fibrosis markers and western blotting for examining signaling pathway activation.

8.4. Age-Dependent Inflammation

A notable feature of Pip4k2c knockout mice is the development of age-dependent inflammation . While these mice appear normal with no specific abnormalities until around 8 months of age, older mice (8-14 months) display increased immune infiltrates in various tissues and elevated levels of proinflammatory cytokines in plasma . Table 5 summarizes the key phenotypes observed in Pip4k2c knockout mice.

Table 6: PIP4K2C Cardiovascular Effects and Therapeutic Outcomes

This table summarizes research findings on the cardiovascular effects of PIP4K2C and the therapeutic outcomes of interventions targeting this protein in heart failure models. The data demonstrate that PIP4K2C plays a protective role in the heart during pathological stress, with potential therapeutic applications for gene therapy approaches using modified mRNA delivery systems .

12.2. Current Research Gaps

Despite significant progress in understanding PIP4K2C, several research gaps remain to be addressed. The precise mechanisms by which PIP4K2C regulates autophagy and membrane trafficking are not fully elucidated and require further investigation. The relative contributions of PIP4K2C's catalytic and non-catalytic functions to its biological roles need better characterization. Additionally, the potential interactions between PIP4K2C and other signaling pathways beyond mTORC1 warrant further exploration. In clinical contexts, more research is needed to validate PIP4K2C as a biomarker for disease diagnosis or prognosis and to determine its utility in patient stratification for targeted therapies. Furthermore, while several inhibitors and degraders targeting PIP4K2C have been developed, their pharmacokinetic and pharmacodynamic properties, as well as potential toxicities, require more extensive characterization before clinical translation. The development of improved antibodies with enhanced specificity, sensitivity, and performance across various applications would also facilitate further advances in this field.

12.3. Future Research Directions

Future research on pip4k2c antibodies and PIP4K2C should focus on several promising directions. More detailed structural studies of PIP4K2C, facilitated by high-quality antibodies for protein purification, would provide insights for rational drug design and understanding of protein-protein interactions. Development of conditional and tissue-specific knockout models would help dissect PIP4K2C's functions in different physiological contexts while avoiding systemic effects. Advanced imaging techniques using fluorescently labeled antibodies could reveal dynamic changes in PIP4K2C localization during cellular processes such as autophagy and membrane trafficking. In the therapeutic realm, optimization of existing PIP4K2C inhibitors and degraders to enhance potency, selectivity, and drug-like properties would advance their clinical potential. Clinical studies correlating PIP4K2C expression or genetic variants with disease outcomes could validate its utility as a biomarker. Additionally, combination approaches targeting PIP4K2C along with other relevant pathways might enhance therapeutic efficacy in complex diseases such as cancer and neurodegenerative disorders.